CARPAL TUNNEL SYNDROME. Carpal tunnel syndrome
Conditions
Interventions
Intervention 1: Intervention group 1: Ketorolac group 30 mg Alborz Daru group injected under ultrasound guide ide. Intervention 2: Intervention group2: Triamcinolone group 40 mg manufactured by Iran h
Sponsors
Vice chancellor for research, Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Proof of Carpal Tunnel Syndrome Moderate with STEVENS Electrodiogenesis Criteria CMAP latency>4.2msec SNAP latency>3.0msec SNAP latency>3.0msec+low amplitude SNAP NCV across wrist<40m/sec CMAP Amplitude <4mv with SNAPs amplitude <12uv without symptoms of degeneration (fib / psw) in tension in Nidal EMG
Exclusion criteria
Exclusion criteria: Symptoms of atrophy of the tenar Contraindication of corticosteroid injection such as corticosteroid hypersensitivity and injection site infection Treatment of carpal tunnel syndrome with surgery or corticosteroid injection over the past 6 months Traumatic or neoplastic origin of symptoms No consent for injection Symptoms of denervation in electromyography suggestive of severe axonal injury Symptoms of active cervical radiculopathy in electromyography or cervical disc protrusion in MRI
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total score of Carpal Tunnel Syndrome Questionnaire Boston To measure severity of symptoms and dysfunction. Timepoint: Before intervention and 3 months later. Method of measurement: boston carpal tunnel questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hand power. Timepoint: Before intervention and 3 months later. Method of measurement: hand dynamometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmirreza Ghanbari
Tabriz University of Medical Sciences
Outcome results
None listed